Imaging and management of pancreatic cancer Review


Authors: Kobi, M.; Veillette, G.; Narurkar, R.; Sadowsky, D.; Paroder, V.; Shilagani, C.; Gilet, A.; Flusberg, M.
Review Title: Imaging and management of pancreatic cancer
Abstract: Pancreatic cancer is an aggressive disease with rising incidence and high mortality despite advances in imaging and therapeutic options. Surgical resection is currently the only curative treatment, with expanding roles for adjuvant and neoadjuvant chemoradiation. Accurate detection, staging, and post-treatment monitoring of pancreatic cancer are critical to improving survival and imaging plays a central role in the multidisciplinary approach to this disease. This article will provide a broad overview of the imaging and management of pancreatic cancer with a focus on diagnosis and staging, operative and nonoperative treatments, and post-therapeutic appearances after surgery and chemoradiation therapy. © 2019
Keywords: fluorouracil; capecitabine; gemcitabine; paclitaxel; cancer adjuvant therapy; pancreas cancer; neoadjuvant therapy; cancer staging; nuclear magnetic resonance imaging; outcome assessment; positron emission tomography; cancer diagnosis; diagnostic accuracy; sensitivity and specificity; pancreaticoduodenectomy; differential diagnosis; cancer therapy; docetaxel; conservative treatment; tumor recurrence; fluorodeoxyglucose f 18; distal pancreatectomy; chemoradiotherapy; pancreas metastasis; fine needle aspiration biopsy; endoscopic ultrasonography; human; priority journal; article; x-ray computed tomography
Journal Title: Seminars in Ultrasound, CT and MRI
Volume: 41
Issue: 2
ISSN: 0887-2171
Publisher: W.B. Saunders Co-Elsevier Inc.  
Date Published: 2020-04-01
Start Page: 139
End Page: 151
Language: English
DOI: 10.1053/j.sult.2019.12.003
PUBMED: 32446428
PROVIDER: scopus
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Viktoriya Paroder
    60 Paroder